PRME
Prime Medicine, Inc. · Healthcare
10% owner Gv 2019 Gp, L.L.C. sold $1.6M of Prime Medicine, Inc.
Sold$1,575,337
$13.82Price
114,023Shares
−1%Stake
What PRME did after the filing
- The stock from Fri, May 12 close, $12.72
- +16.0%
- S&P 500, same days
- +6.4%
Measured over 30 trading days, to the Jun 27 close.
Traded Wed, May 10. Filed Fri, May 12, 12:16 PM ET, during the session. Returns use the May 12 close and the Jun 27 close. Not investment advice.